BioStock Studio: Acarix CEO on the company's vision

Swedish medtech company Acarix has developed the CADScor System, a product that will help healthcare professionals in diagnosing individuals seeking treatment for symptoms related to coronary artery disease (CAD). The company recently received market approval for the device in the US, and CEO Per Persson visited the BioStock Studio at Medicon Village, Lund to tell us more about, among other things, the discussions with regulatory authorities, Acarix's business strategy and the competitive landscape.

Watch the interview with CEO Per Persson at biostock.se:

https://www.biostock.se/2021/04/biostock-studio-acarix-ceo-on-the-companys-vision/

This is a press release from BioStock - Connecting Innovation & Capital.